Showing 1 - 10 of 28
The cost-effectiveness estimates presented in this article support the NICE guidelines for the use of antiplatelets for the prevention of cardiovascular events. Based on these pharmacoeconomic data alone, aspirin should be prescribed for primary or secondary prevention among patients at high...
Persistent link: https://www.econbiz.de/10011001710
Background: A wide variety of oral antiplatelet trials have been carried out, and a large number of cost-effectiveness estimates based on them have been published. Objective: To assess the cost effectiveness of oral antiplatelet treatments in the prevention of cardiovascular events. Methods: A...
Persistent link: https://www.econbiz.de/10005404994
Persistent link: https://www.econbiz.de/10005549287
Schizophrenia is a chronic disease characterized by periods of relative stability interrupted by acute episodes (or relapses). The course of the disease may vary considerably between patients. Patient histories show considerable inter- and even intra-individual variability. We provide a critical...
Persistent link: https://www.econbiz.de/10005404892
When considering the cost-effectiveness categorization as proposed by the Swedish National Board of Health and Welfare, clopidogrel appears to be associated with costs per QALY that range from intermediate in the total CAPRIE population to low in high-risk atherosclerotic patients. </AbstractSection> Copyright...
Persistent link: https://www.econbiz.de/10011000730
Treatment with RLAI is suggested to result in improved QALYs combined with cost savings compared with haloperidol LAI among the Swedish, high-risk non-compliant schizophrenia patient population. In the general schizophrenia population, RLAI also resulted in positive incremental QALYs and cost...
Persistent link: https://www.econbiz.de/10011000765
<Emphasis Type="Bold">Background: The PCI-CURE (Percutaneous Coronary Intervention-Clopidogrel in Unstable Angina to Prevent Recurrent Events) and CREDO (Clopidogrel for the Reduction of Events During Observation) studies have demonstrated that, in addition to aspirin, pre-treatment with clopidogrel followed by...</emphasis>
Persistent link: https://www.econbiz.de/10011001669
Background: In Sweden, risperidone long-acting injectable (RLAI) is generally used in a population of schizophrenia patients who are at a high risk of being non-compliant. However, RLAI might also be suitable for use in the general schizophrenia population. Objectives: To analyse the clinical...
Persistent link: https://www.econbiz.de/10008506287
This paper presents a Monte Carlo simulation study of the bootstrap algorithm proposed by Lothgren and Tambour for calculation of bootstrap confidence intervals for the firm-specific Data Envelopment Analysis (DEA) Malmquist productivity index. The simulation results indicate that the coverage...
Persistent link: https://www.econbiz.de/10009207658
This paper presents a primal-based approach for specification and estimation of multiple-output production frontiers that allows simultaneous identification and estimation of determinants of technical inefficiency. The proposed model extends the technical efficiency effects model by Battese and...
Persistent link: https://www.econbiz.de/10009210165